Migraine device during pregnancy: new safety data emerges
NCT ID NCT05464069
First seen Nov 01, 2025 · Last updated May 13, 2026 · Updated 30 times
Summary
This study checked if using the Nerivio device for migraine headaches during pregnancy and up to 3 months after birth is safe. It compared 145 women with migraine who used Nerivio to those who did not, looking at baby's birth weight, delivery timing, and miscarriage rates. The goal was to see if Nerivio affects pregnancy health.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MIGRAINE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Theranica USA
Montclair, New Jersey, 07042, United States
-
University of California San Diego (UCSD)
San Diego, California, 92037, United States
Conditions
Explore the condition pages connected to this study.